Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 CoviDx™ Rapid Antigen Test

NCT04750629 is registered in ClinicalTrials.gov with Lumos Diagnostics as lead sponsor.

NCT NCT04750629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04750629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 CoviDx™ Rapid Antigen Test
Lead sponsor
Lumos Diagnostics
Phase
Observational
Overall status
Completed
Start date
February 8, 2021
Completion date
May 14, 2021
Enrollment
140 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, sars-cov-2